CompaniesCombangio

Combangio

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

103

By Phase

PHASE2: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
NCT05727878
Hover over trial bars to see details

Recent Trials

NCT05727878Lead Sponsor
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
PHASE2Terminated
103 participants
Started: Feb 7, 2023 · Completed: Oct 19, 2025
Related Companies
Kala Pharmaceuticals
acquired